Serum Hepcidin Levels in Breast Cancer Patients: Investigating the Correlation to Tumor Stage—A Cross‐Sectional Study
These findings suggest that serum hepcidin may serve as a potential biomarker to monitor disease progression in breast cancer patients. CRP could be a positive-regulator for hepcidin in breast cancer.
Authors
- Rama Ibrahim (ORCID: https://orcid.org/0009-0007-1516-6870)
- Zein Al‐Abideen Douba (ORCID: https://orcid.org/0009-0007-5524-8408)
Institutions
- Latakia University (SY)
Publication Details
- Journal
- Health Science Reports
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1002/hsr2.71148
- Citations
- 1
- Primary Topic
- Iron Metabolism and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.77
Funders
- Tishreen University